期刊文献+

泮托拉唑钠肠溶缓释微丸的制备 被引量:4

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole
原文传递
导出
摘要 目的以丙烯酸树脂(Eudragit)为包衣材料,制备泮托拉唑钠(PAZ-Na)肠溶缓释微丸,并对其体外释药性能以及粉体学性质进行考察。方法采用溶液上药法(流化床底喷装置)制备PAZ-Na微丸,用Eudragit RS/RL作为缓释包衣材料,制备缓释微丸;用EudragitL100-55作为肠溶包衣材料,利用微型流化床进行包衣,制备肠溶缓释微丸,并通过单因素实验优化处方及其工艺条件,建立HPLC测定微丸中PAZ-Na,且测定了包衣微丸体外释放度。结果制备的肠溶缓释微丸质量良好,在pH1.2盐酸溶液中2h的释放度<10%;在PBS(pH6.8)中,释放曲线符合一级动力学方程,具有明显的缓释特征。结论PAZ-Na肠溶缓释微丸具有良好的体外缓释效果,制备工艺简单,重现性良好。 OBJECTIVE To prepare sustained release and enteric coated pellets ofpantoprazole-Na (PAZ-Na) with Eudragit as coating material, and study the release characteristics and the micromeritics. METHODS The drug-containing pellets were prepared in the fluid bed by solution layering and then coated in subminiature fluid bed with Eudragit RS/RL and Eudragit L100-55. The formulation of coating material was determined under single-factor investigation. A HPLC method was established to determine the release characteristics of PAZ-Na in vitro. RESULTS The drug-containing sustained release and enteric coated pellets were prepared. In the first 2 h, the coated pellets released less than 10% in pH 1.2 hydrochloric acid solution, and the curve of cumulative drug release was accorded with the first grade equation in PBS (pH 6.8). The pellets showed sustained-release effect. CONCLUSION The coated pellets of PAZ-Na had a good effect of sustained-release in vitro, and the established process and formula were simDle and reDroducible.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第13期997-1001,共5页 Chinese Pharmaceutical Journal
关键词 泮托拉唑钠 缓释微丸 丙烯酸树脂 流化床 pantoprazole sustained-release pellets Eudragit spray fluid-bed
  • 相关文献

参考文献5

  • 1Renata PR,Denise SJ,Maria IR, et al.Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: Effect of the scale of production and process validation[].International Journal of Pharmaceutics.2006
  • 2Schultz P,Kleinebudde P.A new multiparticulate delayed release system. Part I: Dissolution properties and release mechanism.[].Journal of Controlled Release.1997
  • 3J. J. Sousa A. Sousa M. J. Moura F. Podczeck and J. M. Newton.The influence of core materials and film coating on the drug release from coated pellets[].International Journal of Pharmaceutics.
  • 4Kramar A,Vrecer F.Statistical optimization of diclofenac sustained release pellets coated with polymethacrylic films[].International Journal of Pharmaceutics.2003
  • 5Yang ST,Ghebresellassie I.The effect of product bed temperature on the microstructure of aquacoat based controlled release coatings[].International Journal of Pharmaceutics.1990

同被引文献23

  • 1冯金华,邹梅娟,程刚.盐酸青藤碱缓释微丸的制备[J].中国药剂学杂志(网络版),2012(1):7-16. 被引量:5
  • 2Kumar R. Paroxetine : a review of clinical experience. Eur Neurop sychopharmacol, 1997,7 ( Suppl2 ) : 182.
  • 3Rosenzweig-Lipson S, Beyer CE, Hughes ZA, et al. Differentiating antidepressants of the future : efficacy and safety. Pharmacol Ther, 2007,113 ( 1 ) : 134-153.
  • 4First MB. Diagnostic and statistical manual of mental disorders 4nd Ed. Washington DC : American psychiatric association, 1994 : 317- 350.
  • 5Barbui C, Toshiaki AF, Cipriani A. Effectiveness of paroxetine in the treatment of acutemajor depression in adults : a systematic re-ex- amination of published and unpublished data from randomized tri- als. CMAJ,2008,178 ( 3 ) :296-305.
  • 6Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin Therapeut, 2005,25 ( 8 ) :2289 -2304.
  • 7Golden RN, Nemeroff CB, Mc Sorley P, et al. Efficacy and tolera- bility of copirolled-release and immediate-release paroxetine in the treatment of depression. J Clin Psychiatry, 2002,63 ( 7 ) : 577-584.
  • 8Golden RN. Efficacy and tolerability of controlled-release paroxe- tine. Psychopharmacol Bull,2003,37 ( Suppl 1 ) : 176 -186.
  • 9吴君华,柳晨,张瑜,朱赛杰,姜嫣嫣,裴元英.致孔剂调节布地奈德肠溶缓释微丸释放速率的研究[J].中国药学杂志,2007,42(17):1325-1329. 被引量:8
  • 10张丽锋,王锐利,张淑秋.盐酸青藤碱大鼠肠吸收实验研究[J].中国药学杂志,2007,42(20):1556-1557. 被引量:10

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部